PURPOSE To investigate whether retinal blood flow levels after intravitreal bevacizumab (IVB) treatment are correlated with the outcomes of patients with macular edema secondary to central retinal vein occlusion. METHODS This retrospective observational case study enrolled 44 cases nonischemic central retinal vein occlusion. In each patient, visual acuity, central retinal thickness, and mean ...

Central Retinal Vein Occlusion (CRVO) is a common disease causing loss of vision and even blindness. Although CRVO is among the most common vascular disorders affecting the retina, second in prevalence only to diabetic retinopathy, and it has been known for more than 150 years, there is a great deal of confusion regarding its management. The pathogenesis of CRVO is multifactorial with both loca...

BACKGROUND Ocular vascular occlusions following intraocular procedures are a rare complication. We report a case series of patients with retinal vascular occlusions or anterior ischemic optic neuropathy (AION) after anterior and posterior segment surgery and demonstrate possible risk factors. METHODS Observational case series. RESULTS In ten patients, vascular occlusions were observed withi...

PURPOSE To investigate risk factors for central retinal vein occlusion (CRVO). DESIGN Retrospective case-control study. METHODS Consecutive patients with CRVO examined from July 1, 2005 through July 31, 2006 were compared with an historical gender- and age-matched control group of patients with ocular problems other than vascular occlusive disease from the same referral practice. Risk facto...

This prospective study aimed to investigate metamorphopsia in eyes with central retinal vein occlusion (CRVO) and included 28 eyes (28 patients) with unilateral CRVO that had macular edema (ME) in the acute phase. The ME was treated with anti-vascular endothelial growth factor agents. At baseline and at 1 and 6 months after initiation of treatment, quantitative measurements of metamorphopsia we...